Herve Hoppenot

Herve Hoppenot

Director/Board Member at BICYCLE THERAPEUTICS PLC

Net worth: 10 M $ as of 2026-06-29

66 year
Health Technology
Commercial Services
Process Industries

Profile

Herve Hoppenot holds the position of Chairman, President & Chief Executive Officer of Incyte Corp. He is also on the board of Biotechnology Innovation Organization, Cellectis SA and Pharmaceutical Research & Manufacturers of America. In his past career he was President at Novartis Oncology, Inc., President for Novartis Pharmaceuticals Corp., Head-US Oncology Business Unit at Aventis SA, Vice President-Oncology Division at Aventis Pharmaceuticals, Inc., Principal at Rhone Poulenc AG, Inc. and Head-US Oncology Business Unit at Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-13 83,411 ( 0.04% ) 9 M $ 2026-06-29
2026-04-12 13,258 ( 0.03% ) 56 214 $ 2026-06-29
-.--%
2026-06-07 0 ( -.--% ) - $ 2026-06-29

Herve Hoppenot active positions

CompaniesPositionStart
BICYCLE THERAPEUTICS PLC Director/Board Member 2025-09-07
Director/Board Member -
Director/Board Member -
Director/Board Member 2021-10-31
Chairman 2025-10-05

Former positions of Herve Hoppenot

CompaniesPositionEnd
INCYTE CORPORATION Chief Executive Officer 2025-06-25
CELLECTIS S.A. Director/Board Member 2023-06-26
President 2013-12-31
President 2013-12-31
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Herve Hoppenot's experience

Training of Herve Hoppenot

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Health Technology

Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Herve Hoppenot